Qelbree-led growth, Sage acquisition synergies, and <4x forward P/S support ~25% upside into 2026. Click for more on SUPN ...
You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events (including everything from Summerfest to the Milwaukee Film Festival), access ...
Treatment with SKY-0515 results in dose-dependent reductions of mHTT protein in blood of 62% at the 9mg dose, and ...
Beth Kindig from Tech Insider Network and Andres Cardenal from The Data Driven Investor discuss their top growth picks for 2026: Bloom Energy and MercadoLibre.
STOCKHOLM, SE / ACCESS Newswire / February 3, 2026 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR)(STO:ALZCUR)(FRA:AC6), a ...
Newron Pharmaceuticals notes new publication highlighting clinically meaningful benefits of evenamide as an adjunctive treatment in schizophrenia ...
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (Nasdaq: ANL) (the “Company” or ...
Data published in Molecular PsychiatryAd Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, February 3, 2026-Addex Therapeutics (SIX: ...
An entry with a green overhang joins two volumes: a white gabled one for the whole family, and a black one that’s off limits ...
Disrupting left superior frontal sulcus selectively impaired perceptual but not value-based decisions, revealing segregated ...
AIM ImmunoTech Inc. (NYSE American: AIM) - AIM ImmunoTech Inc. ("AIM" or the "Company"), an immuno-pharma company focused on the research and development ...
My father, like so many suburban dads raised in the sweet spot of the late 20th century, was a terrible golfer. He knew it. His friends knew it. And after five minutes on the course with him as his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results